According to The Economist, China is making rapid progress in autonomous vehicles and pharmaceutical development. These industries represent the next wave of Chinese technological leadership that could reshape global markets.
JSE-listed Exxaro Resources is making a major renewable energy push through its Cennergi subsidiary. The deal involves acquiring majority stakes in two operational renewable assets totaling 213MW capacity.
Paradox Interactive has taken a $37 million write-down on Vampire: The Masquerade – Bloodlines 2 after disappointing sales. CEO Fredrik Wester admitted the publisher misjudged the market and took full responsibility for the sequel’s commercial failure.
Nvidia’s November was anything but smooth. The chip giant saw its stock tumble 11% amid Google competition fears and vocal critics like Michael Burry questioning its AI bubble position. Even record earnings couldn’t fully calm investor nerves.
The studio behind Gears Tactics is facing extensive redundancies following its acquisition by unnamed private equity investors. This comes after the cancellation of Transformers: Reactivate earlier this year and marks another blow to the UK games industry.
A new study reveals Trump’s 2025 tariffs directly contributed to higher consumer prices. Researchers found imported goods prices jumped 5.4% while domestic goods rose 3%. The tariffs effectively function as a regressive tax hitting all consumers.
Multiple London councils including Kensington and Chelsea, Westminster, and Hammersmith & Fulham are dealing with a significant cyberattack. The incident has forced officials to shut down networks and phone lines while activating emergency response plans. Investigations with UK law enforcement are o
Microsoft is prioritizing AI buzzwords over fixing fundamental Windows problems, while Xbox and Surface face serious challenges. The company seems completely disconnected from what users actually want from their products.
Barak Turovsky, GM’s inaugural Chief AI Officer, has departed after just eight months in the role. His exit follows other high-profile tech executive departures from the automaker. The timing raises concerns about GM’s push to become a “tech-heavy mobility company.”
Universal DNA testing is rapidly entering mainstream medicine, but it’s creating a minefield of ethical dilemmas. From $4 billion in overdiagnosis costs to genetic discrimination risks, the revolution comes with serious baggage.
